文献速递产科

米索前列醇联合Foley球囊与单用米索前列醇促宫颈成熟的随机对照试验

Misoprostol With Foley Bulb Compared With Misoprostol Alone for Cervical Ripening: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2018-01-01

该随机对照试验纳入200例孕37周及以上、胎膜完整、单胎头位、Bishop评分≤6的孕妇,比较米索前列醇联合经宫颈Foley球囊与单用米索前列醇促宫颈成熟的效果。结果显示联合组从放置米索前列醇至分娩的中位时间显著短于单用组(15.0小时 vs 19.0小时,P=.001),两组剖宫产率及母儿结局无差异。

要点

  • 联合组从放置米索前列醇至分娩的中位时间15.0小时,短于单用组的19.0小时(P=.001)。
  • 按产次分层分析或排除剖宫产后,联合组分娩时间仍显著短于单用组。
  • 两组剖宫产率、缩宫素过度刺激、绒毛膜羊膜炎及新生儿结局无差异。

核心结论

  • 与单用米索前列醇相比,米索前列醇联合经宫颈Foley球囊促宫颈成熟是缩短产程的有效方法。

研究设计与样本

  • 随机对照试验,纳入孕37周及以上、胎膜完整、单胎头位、Bishop评分≤6的孕妇,随机分为联合组和单用组各100例,共200例,采用意向性分析。

主要发现

  • 联合组从放置米索前列醇至分娩的中位时间15.0小时(四分位距11.0-21.8),单用组19.0小时(四分位距14.0-27.3),P=.001。
  • 按产次分层分析或排除剖宫产后,联合组分娩时间仍显著短于单用组。
  • 两组剖宫产率及指征、估计失血量、缩宫素过度刺激率、绒毛膜羊膜炎率及新生儿结局均无差异。

关键数值与推荐

  • 样本量计算显示每组需94例,以80%把握度、α误差0.05检测3小时差异。
  • 纳入标准为孕37周及以上、胎膜完整、单胎、头位、Bishop评分≤6。

临床怎么用

  • 作者认为,与单用米索前列醇相比,米索前列醇联合经宫颈Foley球囊促宫颈成熟是缩短产程的有效方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the hypothesis that cervical ripening using a combination of misoprostol and a transcervical Foley bulb leads to delivery within a shorter time compared with misoprostol alone. METHODS: This randomized controlled trial was offered to women admitted for cervical ripening. Inclusion criteria were gestational age 37 weeks or greater with intact membranes, singleton fetus, cephalic presentation, and Bishop score 6 or less. Exclusion criteria included, among others, prior uterine surgery, ruptured membranes, and any contraindication to vaginal delivery. Patients were randomized to cervical ripening using misoprostol and a transcervical Foley bulb simultaneously or misoprostol alone. Primary outcome was time from placement of the misoprostol to delivery. Secondary outcomes included time to active phase, time from active phase to delivery, cesarean delivery rate, uterine tachysystole, estimated blood loss, chorioamnionitis, cord pH, 5-minute Apgar score, and neonatal intensive care unit admission. Sample size calculation revealed that 94 participants were required in each group to detect a 3-hour difference with 80% power and α error of 0.05. Intention-to-treat analysis was performed. RESULTS: From September 2015 to July 2016, a total of 200 patients were randomized, 100 to each group. There were no differences between groups with respect to parity, body mass index, gestational age, Bishop score, birth weight, or indication for induction. Time to delivery was significantly shorter in the combined misoprostol-transcervical Foley group: 15.0 (11.0-21.8) hours (median [interquartile range]) vs 19.0 (14.0-27.3) hours in the misoprostol-only group (P=.001). This time difference remained significant after subanalysis by parity or after excluding cesarean deliveries. There was no difference between groups with respect to the rate or indication for cesarean delivery, estimated blood loss, rate of tachysystole, chorioamnionitis, or neonatal outcomes. CONCLUSION: Cervical ripening using misoprostol in combination with a transcervical Foley bulb is an effective method to shorten the course of labor compared with misoprostol alone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02566005.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Al-Ibraheemi Z, Brustman L, Bimson BE, et al. Misoprostol With Foley Bulb Compared With Misoprostol Alone for Cervical Ripening: A Randomized Controlled Trial. Obstet Gynecol. 2018. PMID: 29215514. doi:10.1097/AOG.0000000000002403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。